TenderFinder

GlaxoSmithKline Australia Pty Ltd

ABN 47100162481

Total awarded

$2.61B

Contracts

32

Agencies

2

Annual run-rate

$431.0M

Steady. Annualised run-rate over the last four complete quarters is broadly level against the four quarters before it.

Contract value over time

GlaxoSmithKline Australia Pty Ltd annualised contract run-rate by quarterAnnualised run-rate spreads each contract's value evenly across its term, so a multi-year renewal does not read as a spike in growth. Switch to raw award value to see the value booked on the day each contract was signed. Quarters past the last complete one are work already under contract, not a forecast.already contracted$0$50.0M$100.0M$150.0M$200.0M201620172018201920202021202220232024202520262027GlaxoSmithKline Austr...

Annualised run-rate spreads each contract's value evenly across its term, so a multi-year renewal does not read as a spike in growth. Switch to raw award value to see the value booked on the day each contract was signed. Quarters past the last complete one are work already under contract, not a forecast.

What they supply

Product or service areaValueContractsShare
Drugs and Pharmaceutical Products$2.59B3199.1%
Comprehensive health services$23.2M10.9%

Who buys from them

Department of Health and Aged Care$1.33B
Department of Health, Disability and Ageing$1.28B

Ending in the next 12 months

$415.0M of contracted work reaches its end date. See everything ending soon.

  • Supply of Essential Vaccines to the National Immunisation ProgramDepartment of Health, Disability and Ageing · ends 2027-06-29$415.0M

How they win work

95.1% of this supplier's contract value was won through open tender. A low figure means most work is awarded through limited tender, which usually signals an entrenched incumbent.

Recent contracts

  • Supply of Essential Vaccines to the National Immunisation ProgramDepartment of Health, Disability and Ageing · 2026-07-02$415.0MAusTender
  • Supply of Essential Vaccines to the National Immunisation ProgramDepartment of Health, Disability and Ageing · 2025-06-27$431.0MAusTender
  • Supply of Essential Vaccines to the National Immunisation ProgramDepartment of Health, Disability and Ageing · 2024-07-10$437.3MAusTender
  • Supply of Essential VaccinesDepartment of Health and Aged Care · 2023-08-01$504.4MAusTender
  • Supply of Essential VaccinesDepartment of Health and Aged Care · 2022-07-26$126.2MAusTender
  • Supply of Essential VaccinesDepartment of Health and Aged Care · 2021-06-30$123.8MAusTender
  • Supply of Essential Vaccines to the National Immunisation ProgramDepartment of Health and Aged Care · 2020-06-11$106.2MAusTender
  • Supply of Essential VaccinesDepartment of Health and Aged Care · 2019-06-27$63.7MAusTender
  • Supply of Essential VaccinesDepartment of Health and Aged Care · 2019-06-27$47.1MAusTender
  • Supply of Essential Vaccines to the NIP (GSK) (MMR,MMRV,DTPa,dTpa,DTPa-IPV,HepB,Rota,Flu)Department of Health and Aged Care · 2018-06-29$63.9MAusTender
  • Supply of Essential Vaccines to the NIP (GSK) (DTPa-hepB-IPV-Hib, 2018 - Influenza)Department of Health and Aged Care · 2018-06-29$57.2MAusTender
  • Supply of Maternal Pertussis Vaccine to the National Immunisation ProgramDepartment of Health and Aged Care · 2018-06-12$156KAusTender

Compare with similar suppliers

GlaxoSmithKline vs BUPA HEALTH SERVICES PTY LTDGlaxoSmithKline vs CSL BEHRING (AUSTRALIA) PTY LTDGlaxoSmithKline vs Seqirus (Australia) Pty LtdGlaxoSmithKline vs ASPEN MEDICAL PTY LIMITEDGlaxoSmithKline vs SAAB AUSTRALIA PTY LTD

Get told when work like this comes up for renewal

We will email you when contracts in the same area as GlaxoSmithKline Australia Pty Ltd approach their end date, so you can position before the replacement goes to market. Free, and you can unsubscribe from any email.

Federal contracts only. This is published AusTender data for Commonwealth agencies. It does not include state or territory contracts.

Figures are calculated from published AusTender contract notices. Verify on AusTender.

Last recalculated 2026-07-30.